108 related articles for article (PubMed ID: 21802328)
1. Impact of growing up with Fabry disease on achievement of psychosocial milestones and quality of life.
Bouwman MG; Maurice-Stam H; Linthorst GE; Hollak CE; Wijburg FA; Grootenhuis MA
Mol Genet Metab; 2011 Nov; 104(3):308-13. PubMed ID: 21802328
[TBL] [Abstract][Full Text] [Related]
2. Pediatric Fabry disease.
Ries M; Gupta S; Moore DF; Sachdev V; Quirk JM; Murray GJ; Rosing DR; Robinson C; Schaefer E; Gal A; Dambrosia JM; Garman SC; Brady RO; Schiffmann R
Pediatrics; 2005 Mar; 115(3):e344-55. PubMed ID: 15713906
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry.
Hopkin RJ; Bissler J; Banikazemi M; Clarke L; Eng CM; Germain DP; Lemay R; Tylki-Szymanska A; Wilcox WR
Pediatr Res; 2008 Nov; 64(5):550-5. PubMed ID: 18596579
[TBL] [Abstract][Full Text] [Related]
5. The impact of fever/hyperthermia in the diagnosis of Fabry: A retrospective analysis.
Verrecchia E; Zampetti A; Antuzzi D; Ricci R; Ferri L; Morrone A; Feliciani C; Dagna L; Manna R
Eur J Intern Med; 2016 Jul; 32():26-30. PubMed ID: 27083555
[TBL] [Abstract][Full Text] [Related]
6. Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry disease.
Wagner M; Krämer J; Blohm E; Vergho D; Weidemann F; Breunig F; Wanner C
BMC Nephrol; 2014 Nov; 15():188. PubMed ID: 25432518
[TBL] [Abstract][Full Text] [Related]
7. Growing into disability benefits? Psychosocial course of life of young adults with a chronic somatic disease or disability.
Verhoof E; Maurice-Stam H; Heymans H; Grootenhuis M
Acta Paediatr; 2012 Jan; 101(1):e19-26. PubMed ID: 21767313
[TBL] [Abstract][Full Text] [Related]
8. Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort study.
Arends M; Körver S; Hughes DA; Mehta A; Hollak CEM; Biegstraaten M
J Inherit Metab Dis; 2018 Jan; 41(1):141-149. PubMed ID: 29039131
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life and psychosocial developmental trajectory in young female beneficiaries with JIA.
Haverman L; Verhoof EJ; Maurice-Stam H; Heymans HS; Gerlag DM; van Rossum MA; Grootenhuis MA
Rheumatology (Oxford); 2012 Feb; 51(2):368-74. PubMed ID: 22179727
[TBL] [Abstract][Full Text] [Related]
10. Enzyme replacement therapy in two Japanese siblings with Fabry disease, and its effectiveness on angiokeratoma and neuropathic pain.
Furujo M; Kubo T; Kobayashi M; Ohashi T
Mol Genet Metab; 2013 Nov; 110(3):405-10. PubMed ID: 23906479
[TBL] [Abstract][Full Text] [Related]
11. Fabry disease 'The New Great Imposter': results of the French Observatoire in Internal Medicine Departments (FIMeD).
Lidove O; Kaminsky P; Hachulla E; Leguy-Seguin V; Lavigne C; Marie I; Maillot F; Serratrice C; Masseau A; Chérin P; Cabane J; Noel E;
Clin Genet; 2012 Jun; 81(6):571-7. PubMed ID: 21623772
[TBL] [Abstract][Full Text] [Related]
12. Cognitive functioning and depressive symptoms in Fabry disease: A follow-up study.
Körver S; Geurtsen GJ; Hollak CEM; van Schaik IN; Longo MGF; Lima MR; Dijkgraaf MGW; Langeveld M
J Inherit Metab Dis; 2020 Sep; 43(5):1070-1081. PubMed ID: 32510623
[TBL] [Abstract][Full Text] [Related]
13. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.
Ortiz A; Oliveira JP; Waldek S; Warnock DG; Cianciaruso B; Wanner C;
Nephrol Dial Transplant; 2008 May; 23(5):1600-7. PubMed ID: 18175781
[TBL] [Abstract][Full Text] [Related]
14. Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry.
Wilcox WR; Oliveira JP; Hopkin RJ; Ortiz A; Banikazemi M; Feldt-Rasmussen U; Sims K; Waldek S; Pastores GM; Lee P; Eng CM; Marodi L; Stanford KE; Breunig F; Wanner C; Warnock DG; Lemay RM; Germain DP;
Mol Genet Metab; 2008 Feb; 93(2):112-28. PubMed ID: 18037317
[TBL] [Abstract][Full Text] [Related]
15. Quality of life of patients with Fabry disease.
Gold KF; Pastores GM; Botteman MF; Yeh JM; Sweeney S; Aliski W; Pashos CL
Qual Life Res; 2002 Jun; 11(4):317-27. PubMed ID: 12086117
[TBL] [Abstract][Full Text] [Related]
16. Physical function is impaired but quality of life preserved in patients with fibrous dysplasia of bone.
Kelly MH; Brillante B; Kushner H; Gehron Robey P; Collins MT
Bone; 2005 Sep; 37(3):388-94. PubMed ID: 15963775
[TBL] [Abstract][Full Text] [Related]
17. Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease.
Lenders M; Hennermann JB; Kurschat C; Rolfs A; Canaan-Kühl S; Sommer C; Üçeyler N; Kampmann C; Karabul N; Giese AK; Duning T; Stypmann J; Krämer J; Weidemann F; Brand SM; Wanner C; Brand E
Orphanet J Rare Dis; 2016 Jun; 11(1):88. PubMed ID: 27356758
[TBL] [Abstract][Full Text] [Related]
18. Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice.
Terryn W; Cochat P; Froissart R; Ortiz A; Pirson Y; Poppe B; Serra A; Van Biesen W; Vanholder R; Wanner C
Nephrol Dial Transplant; 2013 Mar; 28(3):505-17. PubMed ID: 23234755
[TBL] [Abstract][Full Text] [Related]
19. Fabry disease: a review of current management strategies.
Mehta A; Beck M; Eyskens F; Feliciani C; Kantola I; Ramaswami U; Rolfs A; Rivera A; Waldek S; Germain DP
QJM; 2010 Sep; 103(9):641-59. PubMed ID: 20660166
[TBL] [Abstract][Full Text] [Related]
20. Fabry disease: treatment and diagnosis.
Rozenfeld PA
IUBMB Life; 2009 Nov; 61(11):1043-50. PubMed ID: 19859978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
